SeaStar Medical
SeaStar Medical is a medical technology company focused on redefining extracorporeal therapies to mitigate the effects of excessive inflammation on vital organs. Their innovative solutions, particularly the Selective Cytopheretic Device (SCD), aim to improve outcomes for critically ill patients by addressing dysregulated immune responses that can lead to severe complications such as acute kidney injury and multi-organ failure.
SeaStar Medical
3513 Brighton Blvd, Suite 410, Denver, CO 80216
Patents
What We Do
A patented cell-directed extracorporeal therapy designed to target and neutralize activated neutrophils and monocytes, which are key immune cells involved in hyperinflammation. The SCD aims to restore immune balance and improve patient outcomes in critically ill patients.
A humanitarian medical device for treating pediatric patients with acute kidney injury (AKI) due to sepsis or septic conditions. It is FDA approved and integrates with existing hemodialysis systems.